A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT06313957 · RECRUITING

Trial details

NCT number: NCT06313957
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed B-cell Non-Hodgkin Lymphoma Refractory B-cell Non-Hodgkin Lymphoma

Start date: 2024-03-14
Primary completion: 2026-09-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.